GJA4 Antibody

What is GJA4 protein and why is it significant for research?

GJA4 encodes the gap junction protein alpha-4 (also known as connexin 37 or Cx37), a transmembrane protein that forms gap junctions between cells. This protein functions in blood vessel development and ion transport between cells. The human GJA4 has 333 amino acid residues with a protein mass of 37.4 kDa. It's primarily localized in cell membranes and widely expressed across many tissue types. Research significance stems from its roles in vascular development, cellular communication, and involvement in several pathological conditions including colorectal cancer and vascular malformations .

How should researchers choose the appropriate GJA4 antibody for their experimental needs?

Selection should be based on:

• Application compatibility: Verify the antibody has been validated for your specific application (WB, IHC, IF, ELISA, Flow Cytometry)

• Species reactivity: Ensure cross-reactivity with your study species (human, mouse, rat)

• Epitope location: Consider antibodies targeting different domains depending on research questions

• Clonality: Polyclonal antibodies offer higher sensitivity while monoclonal antibodies provide greater specificity

• Validation evidence: Review provided validation images showing expected molecular weight (~37 kDa) and appropriate tissue localization

What are the recommended positive and negative controls for GJA4 antibody experiments?

Positive controls:

• Human U20S, K562, and HeLa whole cell lysates (validated by Western blot)

• Mouse and rat brain tissue lysates

• Vascular endothelial tissue sections for IHC/IF

• Fibroblasts from colorectal cancer stroma

Negative controls:

• Tissue known to lack GJA4 expression

• Isotype control antibodies (e.g., rabbit IgG at equivalent concentration)

• Non-template controls for PCR-based validation

• Secondary antibody-only controls to assess background

What are the optimal conditions for Western blot detection of GJA4?

Protocol recommendations:

• Protein loading: 30 μg of whole cell/tissue lysate per lane

• Gel conditions: 5-20% SDS-PAGE gel at 70V (stacking)/90V (resolving) for 2-3 hours

• Transfer: Nitrocellulose membrane at 150 mA for 50-90 minutes

• Blocking: 5% non-fat milk in TBS for 1.5 hours at room temperature

• Primary antibody: 0.5 μg/mL, overnight at 4°C

• Washing: TBS-0.1% Tween, 3 times for 5 minutes each

• Secondary antibody: Anti-rabbit IgG-HRP at 1:5000 dilution for 1.5 hours

• Detection: Enhanced chemiluminescence system

• Expected band size: Approximately 37 kDa

What immunohistochemistry protocols yield optimal results for GJA4 detection?

IHC optimization strategy:

• Sample preparation:

  • FFPE tissues: 4 μm sections on coated slides, dried for 3 hours at 42°C

  • Deparaffinization and rehydration

• Antigen retrieval:

  • Citrate buffer (pH 6.0) with heat treatment

• Blocking and antibody incubation:

  • Block with 4% serum/1% BSA in TBS-T for 1 hour at 20°C

  • Primary antibody incubation: Overnight at 4°C in 2% serum/TBS-T

  • Dilution range: 1:20-1:200 depending on tissue type and antibody

• Detection system:

  • For enhanced sensitivity: Biotinylated secondary antibody (1 hour) followed by streptavidin detection

  • Five washes with TBS-T between steps

How can researchers quantify GJA4 expression levels in tissue samples?

Quantification approaches:

• H-Score method:

  • Evaluate staining intensity: none (0), pale yellow (1), tan (2), dark brown (3)

  • Assess staining proportion: no staining (0), ≤10% positive cells (1), 10-50% (2), >50% (3)

  • Calculate H-Score according to published protocols

• Digital image analysis:

  • Capture standardized images using consistent microscope settings

  • Use software to quantify DAB positivity or fluorescence intensity

  • Normalize to appropriate housekeeping proteins or control tissues

• Molecular quantification:

  • Digital droplet PCR (ddPCR) for precise quantification

  • Minimum requirements: ≥500 droplets for reliable quantification

  • Set minimum fractional abundance threshold (e.g., 0.5%) for positive calls

How is GJA4 expression altered in colorectal cancer and what are the implications?

Expression pattern and significance:
GJA4 is significantly upregulated in colorectal cancer (CRC) tissues compared to normal tissues. Interestingly, it's predominantly expressed on stromal fibroblasts rather than on the cancer cells themselves. Higher GJA4 expression correlates with:

• Advanced pathological stage of CRC

• Worse patient prognosis

• Higher stromal abundance in tumors

• Positive correlation with D2 dimer levels

Mechanistic implications:

• GJA4 expressed on cancer-associated fibroblasts (CAFs) promotes fibroblast activation in CRC

• It enhances epithelial-mesenchymal transition (EMT) through fibroblast-dependent pathways

• May act synergistically with M2 macrophages to limit T cell infiltration by stimulating formation of an immune-excluded desmoplastic barrier

• Low tumor-stroma ratio associated with GJA4 upregulation predicts poor prognosis

• Represents a potential therapeutic target for enhancing tumor immunotherapy

What role does GJA4 play in vascular malformations?

Mutation and functional consequences:
A somatic missense mutation in GJA4, c.121G>T (p.Gly41Cys), has been identified in 96.2% (25/26) of orbital cavernous venous malformation (OCVM) tissues. This mutation was found to be:

• Predominantly present in endothelial cell-enriched fractions of OCVM tissue

• A gain-of-function mutation leading to formation of hyperactive hemichannels

• Associated with loss of cellular integrity when overexpressed in human umbilical vein endothelial cells

The cellular integrity disruption could be rescued by carbenoxolone, a non-specific gap junction/hemichannel inhibitor, suggesting potential therapeutic approaches .

How can GJA4 expression patterns be analyzed in the tumor microenvironment?

Analytical approaches:

• Single-cell transcriptomics:

  • Reveals cell-type specific expression patterns

  • GJA4 is primarily upregulated in myofibroblasts and endothelial cells

  • Enables classification into distinct cell populations (B cells, CD4+ T cells, CD8+ T cells, endothelial cells, epithelial cells, fibroblasts, myofibroblasts, and malignant cells)

• Spatial transcriptomics:

  • Maintains tissue architecture information while analyzing gene expression

  • Helps understand spatial relationships between GJA4+ fibroblasts and other cells

• Multiplex immunofluorescence:

  • Co-staining GJA4 with cell type markers (α-SMA for fibroblasts)

  • Allows visualization of spatial relationships between GJA4+ cells and immune cells

• Bioinformatic correlation analysis:

  • ESTIMATE algorithm reveals positive correlation between GJA4 expression and both immune (R=0.430) and stromal (R=0.631) scores

  • Correlation with M2 macrophage markers suggests immunosuppressive functions

How do mutations in GJA4 affect protein function and what methods can analyze these effects?

Functional analysis approaches:

• Electrophysiological studies:

  • Whole-cell voltage clamp analysis in expression systems (e.g., Xenopus oocytes)

  • Can identify gain-of-function or loss-of-function phenotypes

  • The p.Gly41Cys mutation demonstrates formation of hyperactive hemichannels

• Cellular integrity assays:

  • Overexpression of mutant vs. wild-type GJA4 in relevant cell types

  • Assessment of cell morphology, viability, and function

  • Gap junction inhibitors can be tested for rescue effects

• Molecular modeling:

  • Structural predictions of how mutations affect protein conformation and channel properties

  • Insights into altered protein-protein interactions

• Fluorescent dye transfer assays:

  • Measure intercellular communication efficiency

  • Compare wild-type vs. mutant GJA4 function

What technical challenges exist in studying GJA4 in complex tissues?

Research obstacles and solutions:

• Distinguishing between hemichannel and gap junction functions:

  • Challenge: GJA4 forms both structures with distinct roles

  • Solution: Use specific inhibitors, paired oocyte vs. single oocyte recordings

• Low expression in certain tissues:

  • Challenge: Detection sensitivity limits

  • Solution: Signal amplification methods (TSA, high-sensitivity detection systems)

• Cross-reactivity with other connexins:

  • Challenge: Connexin family members share sequence homology

  • Solution: Validation with knockout tissues/cells, peptide competition assays

• Heteromeric channel formation:

  • Challenge: GJA4 can form mixed channels with other connexins

  • Solution: Co-immunoprecipitation studies, proximity ligation assays

• Dynamic regulation:

  • Challenge: GJA4 expression and localization change with cellular states

  • Solution: Live cell imaging with fluorescently tagged GJA4

How can researchers investigate GJA4's role in modulating the immune microenvironment?

Investigative strategies:

• Connexin clustering analysis:

  • Bioinformatic clustering of connexin expression patterns (C1 vs C2 clusters)

  • Association with immune cell infiltration patterns

  • C1 cluster shows lower M1 macrophage and NK cell infiltration with higher M2 macrophages

• Co-culture experiments:

  • GJA4-expressing fibroblasts with immune cells

  • Measure changes in immune cell phenotype and function

  • Assess T cell infiltration capacity through fibroblast layers

• In vivo models:

  • Lentiviral vectors for GJA4 overexpression or knockdown

  • Subcutaneous injection of modified cells (1×10^7 cells/mouse)

  • Monitoring tumor formation, size measurement (V=1/2ab^2), and immune infiltration

• Inhibitor studies:

  • Gap junction inhibitors to reverse immunosuppressive effects

  • Assessment of immune checkpoint expression

  • Potential synergy with immunotherapy approaches

What are common technical issues with GJA4 antibodies and how can they be resolved?

Problem-solving approaches:

How can researchers ensure antibody specificity for GJA4 versus other connexin family members?

Validation strategies:

• Peptide competition assays:

  • Pre-incubate antibody with immunizing peptide

  • Should eliminate specific signal while non-specific binding remains

• Knockout/knockdown controls:

  • Use GJA4 knockdown cell lines (shGJA4)

  • Compare with wild-type and overexpression models

• Recombinant protein testing:

  • Test against recombinant GJA4 and related connexins

  • Confirm specificity for GJA4 over other family members

• Cross-species reactivity assessment:

  • Human GJA4 shares 90.7% and 92.6% amino acid sequence identity with mouse and rat GJA4

  • Differential reactivity patterns can inform specificity

• Multiple antibody approach:

  • Use antibodies targeting different epitopes

  • Concordant results increase confidence in specificity

What storage and handling procedures maximize GJA4 antibody performance?

Optimal handling guidelines:

• Long-term storage:

  • Store lyophilized antibody at -20°C for up to one year from receipt

  • Avoid repeated freeze-thaw cycles

• Reconstitution:

  • For lyophilized antibodies, add 0.2 ml distilled water to yield 500 μg/ml

  • Some formulations contain stabilizers (e.g., 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na₂HPO₄)

• Working solution storage:

  • After reconstitution, store at 4°C for up to one month

  • For longer storage, aliquot and freeze at -20°C for up to six months

  • Avoid more than two freeze-thaw cycles

• Transportation:

  • Ship with ice packs (not dry ice) for short distances

  • Use temperature loggers for critical shipments

• Quality control:

  • Validate each new lot before use in critical experiments

  • Run positive control samples alongside experimental samples

How might GJA4 serve as a therapeutic target in cancer?

Therapeutic strategies under investigation:

• Targeting GJA4 in cancer-associated fibroblasts:

  • Inhibition may reduce fibroblast activation

  • Could disrupt the formation of immunosuppressive desmoplastic barriers

  • Potential to enhance T cell infiltration into tumors

• Combination with immunotherapy:

  • GJA4 inhibition plus immune checkpoint blockade

  • Targeting the GJA4-M2 macrophage axis

  • Breaking the immunosuppressive tumor microenvironment

• Gap junction modulation:

  • Non-specific inhibitors like carbenoxolone show promise in preliminary studies

  • Development of GJA4-specific peptide inhibitors

  • Small molecule screening for selective inhibitors

• Gene therapy approaches:

  • shRNA or siRNA targeting GJA4 in the tumor stroma

  • CRISPR-based gene editing to correct gain-of-function mutations

  • Delivery challenges remain significant

What novel techniques are advancing our understanding of GJA4 biology?

Cutting-edge methodologies:

• Single-cell analysis:

  • Reveals cellular heterogeneity in GJA4 expression

  • Identifies specific cell populations with highest expression

  • UMAP and violin plots demonstrate GJA4 upregulation in myofibroblasts and endothelial cells

• Spatial transcriptomics:

  • Maps GJA4 expression within intact tissue architecture

  • Correlates with stromal abundance and immune cell infiltration patterns

  • ESTIMATE algorithm quantifies relationships with stromal scores

• Digital droplet PCR (ddPCR):

  • Provides absolute quantification of GJA4 mutation allele frequency

  • Highly sensitive detection of somatic mutations (c.121G>T)

  • Minimum of 500 droplets needed for reliable quantification

• Gap junction functional imaging:

  • Real-time visualization of gap junction communication

  • Fluorescent dye transfer assays

  • Correlation with cellular phenotypes

How does GJA4 contribute to intercellular communication networks in health and disease?

Network-level functions:

• Tumor-stroma communication:

  • GJA4 facilitates crosstalk between cancer-associated fibroblasts and other cells

  • Promotes epithelial-mesenchymal transition through fibroblast-dependent pathways

  • May coordinate collective cellular responses in the tumor microenvironment

• Immune regulation:

  • GJA4+ fibroblasts interact with M2 macrophages to create immunosuppressive niches

  • Influences T cell infiltration patterns in colorectal cancer

  • Potential role in adaptive immune response coordination

• Vascular network integrity:

  • GJA4 mutations affect endothelial cell function

  • Hyperactive hemichannels disrupt cellular integrity

  • Implications for vascular malformation development

• Connexin interactome:

  • Beyond direct cell-cell communication

  • Interaction with signaling pathways and cellular processes

  • Integration with other connexin family members to form heterotypic channels